PhaseBio Pharmaceuticals, Inc. (PHAS)

Free Cash Flow

-$61.82M

TTM · Period ending: · USD

PHAS logo

PHAS Free Cash Flow

Latest reported-$61.82M
PHAS TTM Free Cash Flow (-$11.33M → -$61.82M)
High-resolution chart · PNG

PHAS free cash flow history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

PhaseBio Pharmaceuticals, Inc. Free Cash Flow — Trailing twelve months (TTM) (USD)
Period endingFree Cash Flow (USD)
-61,822,000
-62,695,000
-50,095,000
-39,845,000
-49,080,000
-47,217,000
-61,369,000
-62,594,000
-55,224,000
-56,224,000
-40,554,000
-34,855,000
-29,799,000
-23,347,000
-17,172,000
-12,682,000
-11,330,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.